Birtamimab
Birtamimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Birtamimab is under investigation in clinical trial NCT02312206 (The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis).
| Trade Name | Birtamimab |
| Generic | Birtamimab |
| Birtamimab Other Names | Birtamimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Birtamimab
